Ask AI
ProCE Banner Activity

Key HIV Studies From CROI 2024 Influencing Clinical Practice

Conference Coverage
Podcast Episodes

Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the most clinically relevant new data presented at CROI 2024, including long-acting ART, comorbidities and coinfections, and what’s on the horizon in HIV treatment.

Released: March 29, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Joseph J. Eron, MD

Herman and Louise Smith Distinguished Professor of Medicine
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina

Joseph J. Eron, MD: consultant/advisor/speaker: Gilead, Merck, ViiV; researcher (paid to institution): Gilead; data and safety monitoring board: Taimed.

Monica Gandhi, MD, MPH

Professor of Medicine, UCSF
Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine 
Director, UCSF Center for AIDS Research (CFAR)
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.